NovoCure (NVCR) Short Interest Ratio & Short Volume

Short interest is the volume of NovoCure shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 8,180,000 shares of NVCR short. Learn More on NovoCure's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NVCR shares currently have a short interest ratio of 12.0. Learn More on NovoCure's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of NovoCure: Susquehanna International Group LLP, Jane Street Group LLC, Great Point Partners LLC, Schonfeld Strategic Advisors LLC, SG3 Management LLC, Moore Capital Management LP, Boothbay Fund Management LLC, HAP Trading LLC, Group One Trading L.P., PEAK6 Investments LLC, Bank of America Corp DE, UBS Group AG, Citigroup Inc., Wolverine Asset Management LLC, Cutler Group LLC CA, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

NovoCure saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 8,180,000 shares, an increase of 5.8% from the previous total of 7,730,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to NovoCure: Stevanato Group S.p.A. (1.79%), Inspire Medical Systems, Inc. (4.07%), Globus Medical, Inc. (9.99%), Shockwave Medical, Inc. (3.58%), Merit Medical Systems, Inc. (1.34%), Haemonetics Co. (2.16%), Teleflex Incorporated (3.58%), ICU Medical, Inc. (5.71%), iRhythm Technologies, Inc. (7.38%), Inari Medical, Inc. (7.03%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Enbridge Inc. ($4.29 billion), T-Mobile US, Inc. ($4.17 billion), Charter Communications, Inc. ($3.07 billion), Occidental Petroleum Co. ($2.81 billion), Moderna, Inc. ($2.37 billion), Coinbase Global, Inc. ($2.27 billion), T. Rowe Price Group, Inc. ($1.98 billion), Verisk Analytics, Inc. ($1.94 billion), Extra Space Storage Inc. ($1.88 billion), and Xylem Inc. ($1.61 billion). View all of the most shorted stocks.

Short selling NVCR is an investing strategy that aims to generate trading profit from NovoCure as its price is falling. NVCR shares are trading up $0.77 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for NovoCure occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NVCR, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NVCR, twice per month. The most recent reporting period available is May, 15 2023.